Yiran Liang - Concepedia

Author

Yiran Liang

Qilu Hospital of Shandong University ORCID

Also Known As

Adam L. Aposhian, Liang Yiran, Liang, Yiran, Y. Liang, Yi-Ran Liang, Yiran LIANG, Yiran Liang, Yiran Liang (588568)

413

Publications

Citations

H-Index

142

Concepts

All Affiliations

Qilu Hospital of Shandong University Shandong University Brigham Young University Shandong First Medical University Shandong Tumor Hospital

About

Yiran Liang is an author at Qilu Hospital of Shandong University specializing in medicine, cell biology, and systems biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	24	890
2	Engineering	10	11	557
3	Natural Sciences	6	6	163
4	Education	2	2	27
5	Health Sciences	2	2	34

Yiran Liang

Publications

5.5K

Citations

H-Index

Page 1

	Year	Citations
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer Yuting Sang, Bing Chen, Xiaojin Song, Molecular Therapy	2019	505
RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis Yiran Liang, Xiaojin Song, Yaming Li, Molecular Cancer	2020	391
LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA‐215 Xiaoli Kong, Yi Duan, Yuting Sang, Journal of Cellular Physiology	2018	299
Ultrasensitive single-cell proteomics workflow identifies >1000 protein groups per mammalian cell Yongzheng Cong, Khatereh Motamedchaboki, Santosh A. Misal, Chemical Science	2020	237
Organophosphorus pesticide chlorpyrifos intake promotes obesity and insulin resistance through impacting gut and gut microbiota Yiran Liang, Jing Zhan, Donghui Liu, Microbiome	2019	214
Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28 Bing Chen, Yuting Sang, Xiaojin Song, Theranostics	2021	207
circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the Wnt/beta-catenin pathway Yaming Li, Zekun Wang, Peng Su, Molecular Therapy	2021	191
MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1 Yaming Li, Yiran Liang, Yuting Sang, Cell Death and Disease	2018	187
Improved Single-Cell Proteome Coverage Using Narrow-Bore Packed NanoLC Columns and Ultrasensitive Mass Spectrometry Yongzheng Cong, Yiran Liang, Khatereh Motamedchaboki, Analytical Chemistry	2020	175
circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer Yiran Liang, Xiaojin Song, Yaming Li, Oncogene	2019	160

Page 1